Please join us as MITCNC hosts the second Bay Area with/in/sight lecture series from the David H. Koch Institute for Integrative Cancer Research at MIT. We invite you to enjoy the networking reception, mingle with fellow guests and scientists, and join us for a series of informative talks about recent exciting progress in the areas of cancer genetics and new treatments based on our understanding of cancer genes.
The event will showcase research from MIT's Dr. Tyler Jacks, PhD, David H. Koch Professor of Biology, Investigator at the Howard Hughes Medical Institute, and Director of the Koch Institute for Integrative Cancer Research. Professor Jacks will discuss work from his laboratory on the development of novel therapeutic strategies that target common genetic alterations in many human cancers.
Dr. Jacks will be joined by Dr. Kevin Shannon, MD, who is the Roma and Marvin Auerback Distinguished Professor in Pediatric Oncology at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr. Shannon, a physician-scientist, will discuss the challenges and opportunities of new cancer medicines from a clinical perspective. Rounding out the program will be Dr. Jeffrey Settleman, PhD. Dr. Settleman is Senior Director of Discovery Oncology at Genentech. He will present research from his own laboratory at Genentech as well as review new cancer therapeutic programs at the company. The panel discussion will be moderated by Dr. Laura D. Attardi, PhD, an Associate Professor in the Departments of Radiation Oncology & Genetics, at Stanford University School of Medicine.